Results 1 to 10 of about 1,083,667 (362)
Some of the next articles are maybe not open access.

Interleukin-22: Immunobiology and Pathology

Annual Review of Immunology, 2015
Jarrod A Dudakov   +2 more
exaly  

Interleukin-10 determines viral clearance or persistence in vivo

Nature Medicine, 2006
David G Brooks, Michael B A Oldstone
exaly  

Interleukin-22 protects intestinal stem cells against genotoxic stress

Nature, 2019
Jakob Zimmermann   +2 more
exaly  

Interleukin 2 Receptor

1998
Philip D. Greenberg, Brad H. Nelson
openaire   +2 more sources

A new assay for interleukin-1 in the presence of interleukin-2 [PDF]

open access: greenJournal of Immunological Methods, 1987
A simple and reliable assay for interleukin-1 (IL-1) is described which has the advantage over other assays that it is independent of interleukin-2 (IL-2) production by the test cells. The assay makes possible the detection of IL-1 in the supernatants of T cell populations. The ability of IL-1 to induce IL-2 receptor expression in the absence of T cell
Falk, Werner   +2 more
openaire   +4 more sources

Cytochalasin B-Induced Membrane Vesicles from Human Mesenchymal Stem Cells Overexpressing IL2 Are Able to Stimulate CD8+ T-Killers to Kill Human Triple Negative Breast Cancer Cells

open access: yesBiology, 2021
Interleukin 2 (IL2) was one of the first cytokines used for cancer treatment due to its ability to stimulate anti-cancer immunity. However, recombinant IL2-based therapy is associated with high systemic toxicity and activation of regulatory T-cells ...
Daria S. Chulpanova   +7 more
doaj   +1 more source

Harnessing Treg Homeostasis to Optimize Posttransplant Immunity: Current Concepts and Future Perspectives

open access: yesFrontiers in Immunology, 2021
CD4+CD25+Foxp3+ regulatory T cells (Tregs) are functionally distinct subsets of mature T cells with broad suppressive activity and have been shown to play an important role in the establishment of immune tolerance after allogeneic hematopoietic stem cell
Shuntaro Ikegawa   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy